Dr Reddy’s Revenue Up 108% To Rs 1,188 Crore in Q1

Final Up to date: July 28, 2022, 17:46 IST Dr Reddy’s underlying enterprise revenues adjusted for…

Stocks to watch today: Tata Motors, Bharti Airtel, Dr Reddy’s, Grasim, and others

Nifty futures on the Singapore Exchange traded higher by 25 points or 0.16 per cent at…

Medley Pharma likely to be sold in Rs 5,000 cr deal – Times of India

Mumbai: Medley pharmaThe Mumbai-based company, a privately held, is on the block. Medicine Major likes Cipla,…

Rising costs may shrink earnings of domestic pharma companies – Times of India

MUMBAI: Domestic pharma companies are facing headwinds from rising input and logistics costs, which could impact…

Mankind to buy 2 brands from DRL – Times of India

MUMBAI: Mankind Pharma has said it has entered into an agreement with Dr Reddy’s ,DRL) to…

Sensex, Nifty start volatility; IT, bank stocks fall – Times of India

Mumbai: Equity Benchmark Sensex Nifty opened on a choppy note on Tuesday, tracking weakness in index…

Next Flavor in Pharma

The growth of Indian pharma companies in the last decade has been driven by the focus…

Stocks that will see action today

Chennai, 9 September Reliance-HCG Healthcare Global Enterprises, a leading specialty healthcare provider in India focused on…